Cargando…
Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds
Cultured primary progenitor cell types are worthy therapeutic candidates for regenerative medicine. Clinical translation, industrial transposition, and commercial implementation of products based on such cell sources are mainly hindered by economic or technical barriers and stringent regulatory requ...
Autores principales: | Laurent, Alexis, Lin, Poyin, Scaletta, Corinne, Hirt-Burri, Nathalie, Michetti, Murielle, de Buys Roessingh, Anthony S., Raffoul, Wassim, She, Bin-Ru, Applegate, Lee Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317026/ https://www.ncbi.nlm.nih.gov/pubmed/32637400 http://dx.doi.org/10.3389/fbioe.2020.00581 |
Ejemplares similares
-
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology
por: Laurent, Alexis, et al.
Publicado: (2020) -
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
por: Laurent, Alexis, et al.
Publicado: (2023) -
Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021) -
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021) -
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care
por: Al-Dourobi, Karim, et al.
Publicado: (2021)